Skip to content

Clinical evaluation of the effect of active respiratory circulation technology (ACBT) combined with vibration expectoration on stroke-associated pneumonia

Clinical evaluation of the effect of active respiratory circulation technology (ACBT) combined with vibration expectoration on stroke-associated pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124406
Enrollment
Unknown
Registered
2026-05-12
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke-associated pneumonia

Interventions

Control group:Routine pulmonary infection care :1. Impaired gas exchange and ineffective airway clearance: Regularly turn over and pat the back, enhance oral care and comprehensive management, promote
2. Prevent potential complications: Take corresponding measures to prevent septic shock, adopt the supine position, increase the return blood volume to the heart, expand the volume, correct acidosis,
Trial group:Based on the control group, the active breathing circulation technique (ACBT) was adopted: 1. Abdominal breathing training - relaxation: The patien

Sponsors

Wenzhou Medical University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with stroke in accordance with the 2015 edition of the "Chinese Classification of Cerebrovascular Diseases 2015" must be confirmed by CT or MRI in all cases; 2. It meets the diagnostic criteria of SAP and is confirmed by chest X-ray; 3. No obvious consciousness disorder, Glasgow Coma Scale score >8, age 55-80 years old; 4. Patients with stable vital signs and no severe cognitive impairment; 5. Those who are willing to accept the treatment plan of this subject and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are patients with unclear consciousness and unstable vital signs; 2. Those with respiratory system diseases such as lung cancer and lung abscess; 3. Patients who are unable to cooperate and complete various evaluations for various reasons (such as those with severe cognitive impairment); 4. Patients with malignant tumors, malignant progressive hypertension, or a history of mental illness; 5. Visitors from other places are not allowed to follow.

Design outcomes

Primary

MeasureTime frame
Clinical pulmonary infection score (CPIS): Including body temperature, white blood cell count, tracheal secretions, oxygenation status, X-ray chest films, the progression of pulmonary infiltration shadows and tracheal aspirate culture.;

Secondary

MeasureTime frame
Cure rate of lung infection: Including cure rate, effective rate and inefficiency; Pulmonary function assessment: Forced expiratory volume in one second (FEV1), maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP).;

Countries

China

Contacts

Public ContactChen Jin

Wenzhou Medical University Second Affiliated Hospital

chen-jin0@outlook.com+86 138 0683 4323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026